Andelko Hrzenjak
Overview
Explore the profile of Andelko Hrzenjak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
957
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haitzmann T, Schindlmaier K, Frech T, Mondal A, Bubalo V, Konrad B, et al.
Cancer Metab
. 2024 Mar;
12(1):9.
PMID: 38515202
Serine and glycine give rise to important building blocks in proliferating cells. Both amino acids are either synthesized de novo or taken up from the extracellular space. In lung cancer,...
2.
Slanovc J, Mikulcic M, Jahn N, Wizsy N, Sattler W, Malle E, et al.
Biochim Biophys Acta Mol Basis Dis
. 2023 Oct;
1870(1):166924.
PMID: 37898426
Lung adenocarcinoma (LUADC) belongs to the most prevalent and lethal cancer types. As 15-deoxy-Δ12,14-prostaglandin J (15d-PGJ) displays anti-oxidative, -inflammatory, and -cancer properties, we investigated whether this cyclopentenone PG, a stable...
3.
Rossmann C, Ranz C, Kager G, Ledinski G, Koestenberger M, Wonisch W, et al.
Pharmaceutics
. 2023 Aug;
15(8).
PMID: 37631325
Metformin is the most commonly prescribed glucose-lowering drug for the treatment of type 2 diabetes. The aim of this study was to investigate whether metformin is capable of impeding the...
4.
Paar M, Aziz F, Sourij C, Tripolt N, Kojzar H, Muller A, et al.
Viruses
. 2023 Jan;
15(1).
PMID: 36680051
People with diabetes have an increased risk of experiencing adverse COVID-19 outcomes. COVID-19 vaccination is, therefore, highly recommended. However, people with diabetes have an inherently elevated risk of thrombotic events...
5.
Robinson I, Bertsch A, Leithner K, Stiegler P, Olschewski H, Hrzenjak A
Cancer Biomark
. 2022 Apr;
34(4):591-606.
PMID: 35431230
Background: The potential of microRNAs (miRNAs) as molecular tumor biomarkers for early diagnosis and prognosis in lung cancer is still unclear. Objective: To analyze expression of miRNAs in A549 lung...
6.
Klingseisen V, Slanovc J, Regouc M, Hrzenjak A
J Nutr Biochem
. 2022 Mar;
106:109003.
PMID: 35346827
Lung cancer belongs to the most frequent and deadliest cancer types worldwide, non-small cell lung carcinoma (NSCLC) being the most frequent type. Development of chemoresistance in NSCLC patients is common...
7.
Mikulcic M, Tabrizi-Wizsy N, Bernhart E, Asslaber M, Trummer C, Windischhofer W, et al.
Int J Mol Sci
. 2021 Nov;
22(21).
PMID: 34769194
Osteosarcoma (OS) is the most common type of bone tumor, and has limited therapy options. 15-Deoxy-Δ-prostaglandin J (15d-PGJ) has striking anti-tumor effects in various tumors. Here, we investigated molecular mechanisms...
8.
Bluemel G, Planque M, Madreiter-Sokolowski C, Haitzmann T, Hrzenjak A, Graier W, et al.
Free Radic Biol Med
. 2021 Sep;
176:34-45.
PMID: 34520823
Cancer cells frequently lack nutrients like glucose, due to insufficient vascular networks. Mitochondrial phosphoenolpyruvate carboxykinase, PCK2, has recently been found to mediate partial gluconeogenesis and hence anabolic metabolism in glucose...
9.
Schilcher I, Stadler J, Lechleitner M, Hrzenjak A, Berghold A, Pregartner G, et al.
Int J Mol Sci
. 2021 Jan;
22(2).
PMID: 33450841
Endothelial lipase (EL) is a strong modulator of the high-density lipoprotein (HDL) structure, composition, and function. Here, we examined the impact of EL on HDL paraoxonase 1 (PON1) content and...
10.
Lesko J, Triebl A, Stacher-Priehse E, Fink-Neubock N, Lindenmann J, Smolle-Juttner F, et al.
Exp Mol Med
. 2021 Jan;
53(1):81-90.
PMID: 33408336
In cancer cells, metabolic pathways are reprogrammed to promote cell proliferation and growth. While the rewiring of central biosynthetic pathways is being extensively studied, the dynamics of phospholipids in cancer...